ImpediMed Limited announced that Managing Director and Chief Executive Officer (CEO) Richard Carreon would be stepping down from the Company effective close of business 26 July 2022 Carlsbad, California. Mr. Carreon has led ImpediMed over the past ten years through the research and development process and achieving commercialisation of the SOZO® Digital Health Platform. Much of the commercial success is based on the largest ever clinical trial conducted in the lymphoedema space, which Mr. Carreon oversaw.

The outcome of the PREVENT trial demonstrated that intervention in patients with early detection of cancer-related lymphoedema using ImpediMed's L-Dex® technology resulted in a lower rate of progression to chronic disease than patients with early detection from volume measurements using a tape measure, a result that is statistically significant. This level I evidence is key to reimbursement and establishing L-Dex as the standard of care. Current board member David Anderson will assume the role of Interim CEO upon Mr. Carreon's departure.

Mr. Anderson has been a member of ImpediMed's board of directors since April 2020 and also served in the capacity of Remuneration Committee Chair. He brings over a 30-year history of leadership in the health care and insurance industries and is an expert on reimbursement strategy, a key pillar for ImpediMed's long-term success. Most recently, Mr. Anderson served for nine years as CEO and President of HealthNow New York (Blue Cross Blue Shield of Western and Northeastern New York), a USD 3.2 billion health care organisation.

He retired from HealthNow following a successful merger with HighMark Health. He has been an entrepreneur, an executive in many facets of the health insurance industry and is well versed in the competitive and highly regulated health care markets. Mr. Anderson brings a diverse and highly successful history of working with medical practices and hospital organizations to develop preferred standards of patient care and third-party insurance reimbursement programs Mr. Anderson continues to serve as a board member of the newly formed HighMark New York companies and is a former board member of the Blue Cross Blue Shield Association and the National Institute of Healthcare Management.